European Companies Search Engine
EU funding (€10.8M): European Virus Archive goes global Hor1 Apr 2015 EU Research and Innovation programme "Horizon"
Overview
Text
European Virus Archive goes global
The overall objective will be to create and mobilise an International network of high calibre centres around a strong European group of institutes selected for their appropriate expertises, to collect, amplify, characterise, standardise, authenticate, distribute and track, mammalian and other exotic viruses. The network of EVAg laboratories including 25 institutions represents an extensive range of virological disciplines. The architecture of the consortium is based on the association of capacities accessible to the partners but also to any end-users through the EVAg web-based catalogue. This concept has been elaborated and tested for its efficiency during the successful EVA project (FP7). The project will integrate more facilities dedicated to high risk pathogen (HRP) manipulation (1 in EVA, 13 in EVAg) The access to products derived from those HRP will be enhanced and for instance the production of diagnostic reagents will be facilitated. The new project will also provide access to high containment biosafety facilities to carry out in vivo studies of infectious disease using natural or models hosts, to look at prophylactic or therapeutic control measures and to develop materials for the evaluation of diagnostic tests, meaning an extensive capacity to service and to training. EVAg will also link up with other network-based virus-associated programmes that exist globally. However, looking further ahead, EVAg is conceived ultimately to be an open entity aiming at developing synergies and complementarity capabilities in such a way as to offer an improved access to researchers. This project will generate the largest collection of mammalian viruses in the world and move beyond the current state-of-the-art to provide an increasingly valuable resource and service to the world’s scientific community, including government health departments, higher education institutes, industry and, through information systems, the general public.
Funded Companies:
| Company name | Funding amount |
| Academisch Ziekenhuis Leiden | €354,143 |
| €93,466 | |
| €650,537 | |
| €323,786 | |
| CHARITE - UNIVERSITAETSMEDIZIN BERLIN | €691,217 |
| Centre National de la Recherche Scientifique Cnrs | €0.00 |
| €80,031 | |
| €323,339 | |
| Erasmus Universitair Medisch Centrum Rotterdam | €411,559 |
| FRIEDRICH LOEFFLER INSTITUT - BUNDESFORSCHUNGSINSTITUT für TIERGESUNDHEIT | €405,843 |
| €1.25 | |
| €26,030 | |
| Fondation Merieux | €57,321 |
| Institut National de la Sante et de la Recherche Medicale | €431,173 |
| Institut Pasteur | €455,375 |
| Institut de Recherche Pour le Developpement | €0.00 |
| €314,268 | |
| €54,756 | |
| €322,807 | |
| €5,866.94 | |
| €56,742 | |
| The Pirbright Institute LBG | €507,286 |
| €633,146 | |
| €0.00 | |
| €160,277 | |
| Universite d'AIX Marseille | €3,760,501 |
| Univerza V Ljubljani | €542,819 |
| Wuhan Institute OF Virology, Chinese Academy OF Sciences | €130,577 |
Source: https://cordis.europa.eu/project/id/653316
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "Academisch Ziekenhuis Leiden - EU funding (€10.8M): European Virus Archive goes global"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
